Zobrazeno 1 - 10
of 13
pro vyhledávání: '"William M Townsend"'
Autor:
Toby A. Eyre, Sally F. Barrington, Jessica Okosun, Clementina Abamba, Rachel M. Pearce, Julia Lee, Ben Carpenter, Charles R. Crawley, Adrian J.C. Bloor, Maria Gilleece, Emma Nicholson, Nimish Shah, Kim Orchard, Ram Malladi, William M. Townsend
Publikováno v:
Haematologica, Vol 108, Iss 3 (2022)
The optimum management approach for patients with relapsed or refractory follicular lymphoma remains uncertain. Autologous stem cell transplantation (autoSCT) is considered a standard option in suitable, younger patients with relapsed follicular lymp
Externí odkaz:
https://doaj.org/article/c09e9d9ca56542648022789e4beb2ceb
Autor:
Claire Roddie, Lorna Neill, Wendy Osborne, Sunil Iyengar, Eleni Tholouli, David Irvine, Sridhar Chaganti, Caroline Besley, Adrian JC Bloor, Ceri H Jones, Ben J Uttenthal, Roderick J Johnson, Robin Sanderson, Kathleen PL Cheok, Maria A. V. Marzolini, William M Townsend, Maeve O'Reilly, Amy A Kirkwood, Andrea Kuhnl
Publikováno v:
Blood Advances.
The impact of bridging therapy (BT) on CD19-directed chimeric antigen receptor T-cell (CD19CAR-T) outcomes in large B-cell lymphoma (LBCL) is poorly characterised. Current practice is guided by physician preference rather than established evidence. I
Autor:
Toby A, Eyre, Sally F, Barrington, Jessica, Okosun, Clementina, Abamba, Rachel M, Pearce, Julia, Lee, Ben, Carpenter, Charles R, Crawley, Adrian J C, Bloor, Maria, Gilleece, Emma, Nicholson, Nimish, Shah, Kim, Orchard, Ram, Malladi, William M, Townsend
Publikováno v:
Haematologica.
The optimum management approach for patients with relapsed or refractory (R/R) follicular lymphoma (FL) remains uncertain. Autologous stem cell transplantation (autoSCT) is considered a standard option in suitable, younger patients with relapsed FL.
Autor:
William M. Townsend, Emma C. Morris
Patients with haematological malignancies require admission to the intensive care unit (ICU) due to the underlying disease, as a consequence of treatment with chemotherapy or after haematopoietic stem cell transplantation. With an increasing numbers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85eb72fef3e846f04c100939e2d9e52c
https://doi.org/10.1093/med/9780199600830.003.0374
https://doi.org/10.1093/med/9780199600830.003.0374
Autor:
William M, Townsend, Ailsa, Holroyd, Rachel, Pearce, Stephen, Mackinnon, Prakesh, Naik, Anthony H, Goldstone, David C, Linch, Karl S, Peggs, Kirsty J, Thomson, Mervyn, Singer, David C J, Howell, Emma C, Morris
Publikováno v:
British Journal of Haematology
The use of allogeneic haematopoietic stem cell transplantation (Allo-HSCT) is a standard treatment option for many patients with haematological malignancies. Historically, patients requiring intensive care unit (ICU) admission for transplant-related
Publikováno v:
American Journal of Ophthalmology. 78:12-23
Autor:
William M. Townsend
Publikováno v:
American Journal of Ophthalmology. 77:80-86
Publikováno v:
American Journal of Ophthalmology. 77:400-412
Publikováno v:
American Journal of Ophthalmology. 73:52-55
Publikováno v:
American journal of ophthalmology. 71(4)